| Subtype-specific intracellular trafficking of α2-adrenergic receptors DA Daunt, C Hurt, L Hein, J Kallio, F Feng, BK Kobilka Molecular pharmacology 51 (5), 711-720, 1997 | 239 | 1997 |
| Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans1 J KALLIO, U PESONEN, K KAIPIO, MK KARVONEN, U JAAKKOLA, ... The FASEB Journal 15 (7), 1242-1244, 2001 | 162 | 2001 |
| Influence of hydroxychloroquine on the bioavailability of oral metoprolol M Somer, J Kallio, U Pesonen, K Pyykkö, R Huupponen, M Scheinin British journal of clinical pharmacology 49 (6), 549-554, 2000 | 124 | 2000 |
| Inhibitory effects of neuroleptics on debrisoquine oxidation in man. EK Syvälahti, R Lindberg, J Kallio, M De Vocht British journal of clinical pharmacology 22 (1), 89, 1986 | 100 | 1986 |
| Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY J Kallio, U Pesonen, MK Karvonen, M Kojima, H Hosoda, K Kangawa, ... The Journal of Clinical Endocrinology & Metabolism 86 (11), 5348-5352, 2001 | 95 | 2001 |
| Neuropeptide Y and Y2‐receptor are involved in development of diabetic retinopathy and retinal neovascularization M Koulu, S Movafagh, J Tuohimaa, U Jaakkola, J Kallio, U Pesonen, ... Annals of medicine 36 (3), 232-240, 2004 | 91 | 2004 |
| Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers. M Koulu, M Scheinin, A Kaarttinen, J Kallio, K Pyykko, J Vuorinen, ... British journal of clinical pharmacology 27 (2), 243-255, 1989 | 79 | 1989 |
| Receptor subtype-induced targeting and subtype-specific internalization of human α2-adrenoceptors in PC12 cells T Olli-Lähdesmäki, J Kallio, M Scheinin Journal of Neuroscience 19 (21), 9281-9288, 1999 | 66 | 1999 |
| Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients K Pettersson-Fernholm, MK Karvonen, J Kallio, CM Forsblom, M Koulu, ... Diabetes Care 27 (2), 503-509, 2004 | 60 | 2004 |
| Changes in diurnal sympathoadrenal balance and pituitary hormone secretion in subjects with Leu7Pro polymorphism in the prepro-neuropeptide Y J Kallio, U Pesonen, U Jaakkola, MK Karvonen, H Helenius, M Koulu The Journal of Clinical Endocrinology & Metabolism 88 (7), 3278-3283, 2003 | 49 | 2003 |
| Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants R Karlsson, J Kallio, J Toppari, M Scheinin, P Kero Hormone Research in Paediatrics 53 (4), 170-176, 2000 | 43 | 2000 |
| Chloroethylclonidine and 2-aminoethyl methanethiosulfonate recognize two different conformations of the human α2A-adrenergic receptor A Marjamäki, H Frang, M Pihlavisto, AM Hoffrén, T Salminen, ... Journal of Biological Chemistry 274 (31), 21867-21872, 1999 | 42 | 1999 |
| Adrenocorticotropin and corticotropin-releasing hormone tests in preterm infants R Karlsson, J Kallio, K Irjala, S Ekblad, J Toppari, P Kero The Journal of Clinical Endocrinology & Metabolism 85 (12), 4592-4595, 2000 | 39 | 2000 |
| Subtype-specific neuronal differentiation of PC12 cells transfected with α2-adrenergic receptors S Taraviras, T Olli-Lähdesmäki, A Lymperopoulos, D Charitonidou, ... European journal of cell biology 81 (6), 363-374, 2002 | 37 | 2002 |
| Debrisoquine oxidation in Parkinson's disease J Kallio, RJ Marttila, UK Rinne, V Sonninen, E Syvälahti Acta neurologica scandinavica 83 (3), 194-197, 1991 | 37 | 1991 |
| Severe hyponatremia caused by intranasal desmopressin for nocturnal enuresis J Kallio, P Rautava, R Huupponen, H Korvenranta Pediatric Nephrology 8 (1), 115-115, 1994 | 34 | 1994 |
| Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio. J Kallio, R Lindberg, R Huupponen, E Iisalo British journal of clinical pharmacology 26 (6), 791-795, 1988 | 33 | 1988 |
| Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice AE Jääskeläinen, S Seppälä, T Kakko, U Jaakkola, J Kallio Neuropeptides 47 (2), 67-73, 2013 | 32 | 2013 |
| The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic … U Jaakkola, U Pesonen, E Vainio-Jylhä, M Koulu, M Pöllönen, J Kallio Experimental and clinical endocrinology & diabetes 114 (04), 147-152, 2006 | 31 | 2006 |
| Antenatal dexamethasone treatment decreases plasma catecholamine levels in preterm infants J Kallio, R Karlsson, J Toppari, T Helminen, M Scheinin, P Kero Pediatric research 43 (6), 801-807, 1998 | 30 | 1998 |
